loading page

Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide.
  • akiko hashimoto,
  • yasuhiro tanaka,
  • isaku shinzato
akiko hashimoto
Nishi Kobe Medical Center
Author Profile
yasuhiro tanaka
Author Profile
isaku shinzato
Author Profile


A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively for APL with CKD

Peer review status:UNDER REVIEW

26 Dec 2020Submitted to Clinical Case Reports
09 Jan 2021Assigned to Editor
09 Jan 2021Submission Checks Completed
13 Jan 2021Reviewer(s) Assigned